Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Mar 8, 2007
Boston Scientific Corporation (NYSE: BSX) today announced several enhancements related to the governance of the company. "Boston Scientific is...
-
Mar 6, 2007
A live webcast and replay of the March 13 conference session will be available
-
Mar 5, 2007
Company looks forward to providing the Committee the information it has requested relating to TAXUS® paclitaxel-eluting coronary stents
-
Feb 28, 2007
Campaign spokesperson - a Formula race car driver, amputee, and chronic pain patient - to promote public awareness
-
Feb 12, 2007
Swedish registry further illustrates the strengths and weaknesses of so-called "real-world" registries when compared to prospective, randomized and actively controlled trials
-
Feb 12, 2007
Articles scheduled for publication in the March 8th edition confirm the safety and efficacy of TAXUS® Express2™ paclitaxel-eluting coronary stent system
-
Feb 5, 2007
DES patients have significantly lower rates of death, heart attack and re-intervention than BMS patients
-
Feb 2, 2007
Company supports the proposed expansion but also supports broader coverage
-
Feb 1, 2007
Company provides guidance for first quarter 2007December 31, 2006, as well as...
-
Jan 31, 2007
Company will webcast its conference call discussing financial results for the fourth quarter and the year ended December 31, 2006 on Thursday, February 1, at 8:30 a.m.